National Institute of Allergy and Infectious Diseases (NIAID): Clinical Trials & Research Profile
Federal / Public Agency (Global / Institutional) · Primary Focus: Infectious Disease and Vaccines
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Federal / Public Agency (Global / Institutional) |
| Primary Therapeutic Area | Infectious Disease and Vaccines |
| Active Phase II & III Studies | 54 active (43 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 185 (81 with California sites) |
| Completed vs Early-Stopped Studies | 99 completed / 32 stopped (17.3% stop rate) |
| Median Closed Enrollment | 94 participants |
| FDA Drugs@FDA Original Approvals | 0 all-time (0 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 97.7% named hospital slots |
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk